glutathione mutations in sclc patients Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming EGFR-Mutant Lung Cancer NRF2 supports non-small cell lung
NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications RETRACTED ARTICLE: Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications Scientific Reports Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies Frontiers Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




